Skip to main content
. 2014 Jun 30;8(3):1043–1050. doi: 10.3892/ol.2014.2298

Figure 3.

Figure 3

miR-320a shows improved prognostic value in advanced-stage breast cancer patients. Kaplan-Meier analysis and log-rank test showing the overall survival of 130 invasive breast cancer patients with low and high miR-320a levels categorized according to (A and B) lymph node status and (C and D) clinical TNM stage. miR-320a, microRNA-320a; TNM, tumor lymph node metastasis.